Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1990 Nov;83(11):693–695. doi: 10.1177/014107689008301107

Survival in acute non-lymphocytic leukaemia following breast cancer.

S D Kaster 1, F F Holmes 1
PMCID: PMC1292914  PMID: 2250264

Abstract

Acute non-lymphocytic leukaemia (ANLL) occurs with increased frequency in women with previously diagnosed breast cancer. Adjuvant radiotherapy and chemotherapy are related to this increase. We studied the interrelationships among age at breast cancer diagnosis, interval to ANLL diagnosis, and survival in 54 women of whom 11 were from Kansas and 43 were from two other published series. Median age at breast cancer diagnosis was 50.5 years, median interval to ANLL diagnosis was 4.8 years, and median survival after ANLL diagnosis was 2.2 months. Increasing age was associated with a decrease of the interval to ANLL diagnosis just short of statistical significance (P = 0.0591). There was no association of survival with either age or the interval to ANLL diagnosis. With an increase in the use of adjuvant therapy in breast cancer there is a need to identify women at greatest risk of subsequently developing ANLL, at present not possible.

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brenner B., Carter A., Sharon R., Tatarsky I. Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases. Oncology. 1984;41(2):83–87. doi: 10.1159/000225798. [DOI] [PubMed] [Google Scholar]
  2. Cadman E. C., Capizzi R. L., Bertino J. R. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases. Cancer. 1977 Sep;40(3):1280–1296. doi: 10.1002/1097-0142(197709)40:3<1280::aid-cncr2820400343>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  3. Carey R. W., Holland J. F., Sheehe P. R., Graham S. Association of cancer of the breast and acute myelocytic leukemia. Cancer. 1967 Jul;20(7):1080–1088. doi: 10.1002/1097-0142(196707)20:7<1080::aid-cncr2820200711>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  4. Coleman C. N., Williams C. J., Flint A., Glatstein E. J., Rosenberg S. A., Kaplan H. S. Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med. 1977 Dec 8;297(23):1249–1252. doi: 10.1056/NEJM197712082972303. [DOI] [PubMed] [Google Scholar]
  5. Ershler W. B., Robins H. I., Davis H. L., Hafez G. R., Meisner L. F., Dahlberg S., Arndt C. Emergence of acute non-lymphocytic leukemia in breast cancer patients. Am J Med Sci. 1982 Sep-Oct;284(2):23–31. doi: 10.1097/00000441-198209000-00004. [DOI] [PubMed] [Google Scholar]
  6. Fisher B., Rockette H., Fisher E. R., Wickerham D. L., Redmond C., Brown A. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol. 1985 Dec;3(12):1640–1658. doi: 10.1200/JCO.1985.3.12.1640. [DOI] [PubMed] [Google Scholar]
  7. Foucar K., McKenna R. W., Bloomfield C. D., Bowers T. K., Brunning R. D. Therapy-related leukemia: a panmyelosis. Cancer. 1979 Apr;43(4):1285–1296. doi: 10.1002/1097-0142(197904)43:4<1285::aid-cncr2820430416>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  8. Gale R. P. Advances in the treatment of acute myelogenous leukemia. N Engl J Med. 1979 May 24;300(21):1189–1199. doi: 10.1056/NEJM197905243002105. [DOI] [PubMed] [Google Scholar]
  9. Haas J. F., Kittelmann B., Mehnert W. H., Staneczek W., Möhner M., Kaldor J. M., Day N. E. Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer. 1987 Feb;55(2):213–218. doi: 10.1038/bjc.1987.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herring M. K., Buzdar A. U., Smith T. L., Hortobagyi G. N., Blumenschein G. R. Second neoplasms after adjuvant chemotherapy for operable breast cancer. Am J Clin Oncol. 1986 Jun;9(3):269–275. doi: 10.1097/00000421-198606000-00018. [DOI] [PubMed] [Google Scholar]
  11. Kingsley E. C., Durie B. G. Prolonged survival in patients with treatment-related leukemia. Scand J Haematol. 1986 Aug;37(2):103–105. doi: 10.1111/j.1600-0609.1986.tb01781.x. [DOI] [PubMed] [Google Scholar]
  12. Lerner H. J. Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer. Cancer Treat Rep. 1978 Aug;62(8):1135–1138. [PubMed] [Google Scholar]
  13. Mansour E. G., Gray R., Shatila A. H., Osborne C. K., Tormey D. C., Gilchrist K. W., Cooper M. R., Falkson G. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. doi: 10.1056/NEJM198902233200803. [DOI] [PubMed] [Google Scholar]
  14. Mehnert W. H., Haas J. F., Kittelmann B., Staneczek W., Möhner M., Kaldor J. M., Day N. E. A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms. IARC Sci Publ. 1986;(78):203–221. [PubMed] [Google Scholar]
  15. Portugal M. A., Falkson H. C., Stevens K., Falkson G. Acute leukemia as a complication of long-term treatment of advanced breast cancer. Cancer Treat Rep. 1979 Feb;63(2):177–181. [PubMed] [Google Scholar]
  16. Rosner F., Carey R. W., Zarrabi M. H. Breast cancer and acute leukemia: report of 24 cases and review of the literature. Am J Hematol. 1978;4(2):151–172. doi: 10.1002/ajh.2830040207. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES